Shut Down

ReadCoor Stock
ReadCoor is pioneering panomic spatial sequencing.
Sign up today and learn more about ReadCoor Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About ReadCoor Stock
ReadCoor is leading the next generation of omics by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with Fluorescent In-situ Sequencing (FISSEQ), a fundamental new technology, which simultaneously integrates high throughput sequencing and three-dimensional morphometric analysis. This uniquely powerful platform will revolutionize the next phase in understanding the panomic landscape and introduce vast new opportunities for important and meaningful clinical insight.
Funding History
September 2016 | $23.0M |
---|---|
December 2016 | $2.5M |
January 2018 | $0 |
Management
Founder, President & CEO
Richard Terry
Founder
George Church
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase